During the past decade, Phonak AG conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Phonak AG" are "Hearing Loss, Bilateral or Unilateral" (1 trials) and "Validation Studies" (1 trials). Many other conditions were trialed in "Phonak AG" in a lesser frequency.

Most popular intervention types in "Phonak AG" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Hearing aid." (1 trials) and "Real-Ear Measurement system integrated in hearing aid fitting software" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phonak AG" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Phonak AG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Phonak AG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Phonak AG, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".